These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17108211)

  • 81. Sex, Age, and Bodyweight as Determinants of Extracellular DNA in the Plasma of Mice: A Cross-Sectional Study.
    Janovičová Ľ; Konečná B; Vokálová L; Lauková L; Vlková B; Celec P
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31454899
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Deoxyribonuclease activity and circulating DNA concentration in blood plasma of patients with prostate tumors.
    Cherepanova AV; Tamkovich SN; Bryzgunova OE; Vlassov VV; Laktionov PP
    Ann N Y Acad Sci; 2008 Aug; 1137():218-21. PubMed ID: 18837950
    [TBL] [Abstract][Full Text] [Related]  

  • 83. EDTA-mediated inhibition of DNases protects circulating cell-free DNA from ex vivo degradation in blood samples.
    Barra GB; Santa Rita TH; de Almeida Vasques J; Chianca CF; Nery LF; Santana Soares Costa S
    Clin Biochem; 2015 Oct; 48(15):976-81. PubMed ID: 25746148
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Nuclear Acids In Human Blood Plasma].
    MANDEL P; METAIS P
    C R Seances Soc Biol Fil; 1948 Feb; 142(3-4):241-3. PubMed ID: 18875018
    [No Abstract]   [Full Text] [Related]  

  • 85. Measurement of deoxyribonuclease I activity in human tissues and body fluids by a single radial enzyme-diffusion method.
    Nadano D; Yasuda T; Kishi K
    Clin Chem; 1993 Mar; 39(3):448-52. PubMed ID: 8448855
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Cell-free nucleic acids as biomarkers in cancer patients.
    Schwarzenbach H; Hoon DS; Pantel K
    Nat Rev Cancer; 2011 Jun; 11(6):426-37. PubMed ID: 21562580
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Free DNA in the serum of cancer patients and the effect of therapy.
    Leon SA; Shapiro B; Sklaroff DM; Yaros MJ
    Cancer Res; 1977 Mar; 37(3):646-50. PubMed ID: 837366
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Circulating cell-free DNA concentration and DNase I activity of peripheral blood plasma change in case of pregnancy with intrauterine growth restriction compared to normal pregnancy.
    Ershova E; Sergeeva V; Klimenko M; Avetisova K; Klimenko P; Kostyuk E; Veiko N; Veiko R; Izevskaya V; Kutsev S; Kostyuk S
    Biomed Rep; 2017 Oct; 7(4):319-324. PubMed ID: 29085628
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Rapid clearance of fetal DNA from maternal plasma.
    Lo YM; Zhang J; Leung TN; Lau TK; Chang AM; Hjelm NM
    Am J Hum Genet; 1999 Jan; 64(1):218-24. PubMed ID: 9915961
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Circulating cell-free DNA: an up-coming molecular marker in exercise physiology.
    Breitbach S; Tug S; Simon P
    Sports Med; 2012 Jul; 42(7):565-86. PubMed ID: 22694348
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Deoxyribonuclease activity in biological fluids of healthy donors and cancer patients.
    Tamkovich SN; Cherepanova AV; Bryzgunova OE; Kolesnikova EV; Permyakova VI; Vlassov VV; Laktionov PP
    Bull Exp Biol Med; 2008 Jul; 146(1):89-91. PubMed ID: 19145360
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Circulating DNA. Its origin and fluctuation.
    van der Vaart M; Pretorius PJ
    Ann N Y Acad Sci; 2008 Aug; 1137():18-26. PubMed ID: 18837919
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Immunochemical assay for deoxyribonuclease activity in body fluids.
    Cherepanova A; Tamkovich S; Pyshnyi D; Kharkova M; Vlassov V; Laktionov P
    J Immunol Methods; 2007 Aug; 325(1-2):96-103. PubMed ID: 17618645
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Colorimetric determination of DNase I activity with a DNA-methyl green substrate.
    Sinicropi D; Baker DL; Prince WS; Shiffer K; Shak S
    Anal Biochem; 1994 Nov; 222(2):351-8. PubMed ID: 7864358
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Circulating cell free DNA: Preanalytical considerations.
    El Messaoudi S; Rolet F; Mouliere F; Thierry AR
    Clin Chim Acta; 2013 Sep; 424():222-30. PubMed ID: 23727028
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cell-free nucleic acid fragmentomics: A non-invasive window into cellular epigenomes.
    Sirajee AS; Kabiraj D; De S
    Transl Oncol; 2024 Nov; 49():102085. PubMed ID: 39178576
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Tumor- and Fibroblast-Derived Cell-Free DNAs Differently Affect the Progression of B16 Melanoma In Vitro and In Vivo.
    Filatova AA; Alekseeva LA; Sen'kova AV; Savin IA; Sounbuli K; Zenkova MA; Mironova NL
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791341
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Nucleolin-Targeting AS1411 Aptamer-Conjugated Nanospheres for Targeted Treatment of Glioblastoma.
    Seo K; Hwang K; Nam KM; Kim MJ; Song YK; Kim CY
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675227
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Tumor-derived cell-free DNA and circulating tumor cells: partners or rivals in metastasis formation?
    Witz A; Dardare J; Betz M; Gilson P; Merlin JL; Harlé A
    Clin Exp Med; 2024 Jan; 24(1):2. PubMed ID: 38231464
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.